NCT07874139 · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE
(PRESIDE)
What this study is about
This observational, multicentric forward-looking study aims to understand the prevalence and burden of antimicrobial resistance (AMR) in people with chronic lung diseases (CLD) across the globe, understanding also geographical variability and the risk factors for acquiring AMR. The primary objective is to understand the prevalence and burden of AMR in CLD both at a local and gloval level.
View original scientific description
This observational, multicentric prospective study aims to understand the prevalence and burden of antimicrobial resistance (AMR) in people with chronic lung diseases (CLD) across the globe, understanding also geographical variability and the risk factors for acquiring AMR. The primary objective is to understand the prevalence and burden of AMR in CLD both at a local and gloval level.
Primary outcome measures
Prevalence of antimicrobial resistance in chronic lung diseases
Time frame: Five years from the beginning of the study.
Prevalence and burden of antimicrobial resistance in chronic lung diseases at both local and global levels.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Patients of all ages with any chronic lung disease who, for clinical practice, underwent testingof at least one respiratory biological sample (sputum culture; bronchoaspirate; bronchoalveolar lavage; nasal swab; throat swab) within the 12 months prior to the visit.
- Patients attending an outpatient clinic or hospitalized during the study period
Exclusion criteria
- Patients who have not signed the informed consent form
- Absence of data in the patient record
Where
- Ann Arbor, Michigan
Collaborators
European Respiratory Society, Royal Brompton & Harefield NHS Foundation Trust, Imperial College London
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Oct 14, 2026 · Source of record for eligibility and locations